ONA Therapeutics

📍 Barcelona, Spain🗓 Founded 2019👥 39 employees💰 Last funded May 2026
Biotechnology Research🌐 ona-therapeutics.com
Website LinkedIn
Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives.
6
Total investors
4
Early stage
1
Mid stage
1
Late stage
2019
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
2
Belgium
2
Spain
1
Investor activity2019–2026 · investors recorded per year
20191202032022120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in ONA Therapeutics?
ONA Therapeutics has 6 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did ONA Therapeutics last raise funding?
The most recent investment in ONA Therapeutics recorded on gritt.io was in May 2026.
When was ONA Therapeutics founded?
ONA Therapeutics was founded in 2019.
What industry is ONA Therapeutics in?
ONA Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ONA Therapeutics based?
ONA Therapeutics is headquartered in Barcelona, Spain.